This program, funded under the MRC-BRIG ($150,000 USD), is a research collaboration between Axonova and University of Mauritius.
Axonova has established a library of 60 extracts containing active molecules from a selection of Mauritian medicinal plants that are known either from traditional use, literature or chemical profiles to have central nervous system effects. The extracts have been tested in Axonova pharmacology platform. From all the 60 extracts screened, more than 10 showed interesting neuroprotective properties. Axonova is currently doing further characterization of the lead candidate(s) to determine the mechanism of action and assess the therapeutic properties in cellular models of Alzheimer’s and Parkinson’s diseases.